WuXi Biologics (Cayman) Inc. (WXIBF)
Manufactures biologic drugs and provides contract development services for pharmaceutical companies worldwide.
$4.60+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+13.7%
The outlook
WXIBF is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. Analyst sentiment leans bullish overall. The stock carries a trailing P/E of 27.1, reflecting elevated valuation relative to current earnings.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range44% of the way from its 52-week low to high
Market cap
$18.89B
52-wk high
$5.61
52-wk low
$3.80
50-day avg
$4.35
200-day avg
$4.45
Trailing P/E
27.1